Literature DB >> 34342

Diagnosis and treatment: drugs five years later. Amoxicillin.

H C Neu.   

Abstract

Amoxicillin is an aminopenicillin available in the United States only for oral use. It has an antibacterial activity and spectrum similar to that of ampicillin and is destroyed by gram-positive and gram-negative beta-lactamases. It is more active against enterococci and salmonellae than ampicillin, but less active against Shigella. It is better absorbed than ampicillin from the gastrointestinal tract with blood levels two to two and one half times those of ampicillin. Amoxicillin is an excellent agent to treat otitis media, bacterial sinusitis, bacterial exacerbations of bronchitis, acute lower-urinary-tract infections, gonorrhea, and typhoid. In special settings it may be useful as oral therapy of endocarditis, septic arthritis, and osteomyelitis and as prophylaxis to prevent endocarditis. When the cost of amoxicillin approaches that of ampicillin, it should replace that agent as the oral aminopenicillin of first choice.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 34342     DOI: 10.7326/0003-4819-90-3-356

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  6 in total

1.  The use of antimicrobial drugs in office practice.

Authors:  M R Achong
Journal:  Can Fam Physician       Date:  1982-12       Impact factor: 3.275

Review 2.  Guide to drug dosage in renal failure.

Authors:  W M Bennett
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

Review 3.  Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

4.  Analysis of penicillin-binding protein genes of clinical isolates of Streptococcus pneumoniae with reduced susceptibility to amoxicillin.

Authors:  Mignon du Plessis; Edouard Bingen; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

5.  Double-blind comparative study of two dosage regimens of cefaclor and amoxicillin-clavulanic acid in the outpatient treatment of soft tissue infections.

Authors:  F D Pien
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

6.  An in vitro pharmacodynamic model to simulate antibiotic behavior of acute otitis media with effusion.

Authors:  K Vance-Bryan; T A Larson; M W Garrison; J P Toscano; D M Canafax; J C Rotschafer
Journal:  Pharm Res       Date:  1992-07       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.